by Team Small News | Jun 15, 2025 | Pfizer, Pharma
A US Food and Drug Administration (FDA) advisory panel has rejected Pfizer’s bid to expand the use of its drug Talzenna (talazoparib) to treat metastatic prostate cancer. The panel’s decision was based on the results of a clinical trial that failed to show... by Team Small News | Jun 8, 2025 | Pfizer, Pharma
Pfizer CEO Albert Bourla recently sat down with Reuters for an interview, where he discussed the crucial balance between driving innovation in the pharmaceutical industry and ensuring global access to medicines. Bourla emphasized the importance of finding a middle... by Team Small News | Jun 6, 2025 | Aurobindo Pharma, Pfizer, Pharma
The US Food and Drug Administration (FDA) has granted approval to Aurobindo Pharma for its varenicline tablets, available in 0.5 mg and 1 mg strengths. This approval marks a significant milestone for Aurobindo, as its varenicline tablets are the generic equivalent of... by Team Small News | Jun 4, 2025 | Pfizer, Pharma
The American Society of Clinical Oncology (ASCO) annual meeting was held in Chicago, featuring over 5,000 research abstracts on various cancer treatments and studies. Several pharmaceutical giants and biotech companies presented promising data, including AstraZeneca,... by Team Small News | Jun 1, 2025 | Pfizer, Pharma
A promising experimental treatment for breast cancer, developed by Pfizer and Arvinas, has shown significant results in delaying the progression of the disease. The treatment, called vepdegestrant, was tested in a clinical trial of 624 patients with a specific type of... by Team Small News | May 31, 2025 | Pfizer, Pharma
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured significant presentations from major pharmaceutical companies, including Pfizer, AstraZeneca, and Daiichi Sankyo. The meeting highlighted new data on innovative cancer treatments, showcasing...